Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.
Takagi Y, Hosomi Y, Oshita F, Okamoto H, Seki N, Minato K, Aono H, Yamada K, Okuma Y, Hida N, Sakamoto T, Miura Y, Yomota M, Satoh A, Kunitoh H, Sakamaki K, Shibuya M, Watanabe K.
Takagi Y, et al. Among authors: shibuya m.
BMC Cancer. 2015 Oct 19;15:740. doi: 10.1186/s12885-015-1756-1.
BMC Cancer. 2015.
PMID: 26481215
Free PMC article.
Clinical Trial.